Shares of Madrigal Pharmaceuticals soar on FDA approval for NASH treatment
Conshohocken-based Madrigal Pharmaceutical has emerged as the winner in the race to be the first drug company to secure approval for a treatment targeting a liver disease known as NASH. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 14, 2024 Category: Biotechnology Authors: John George Source Type: news

FDA Approves First Treatment for Patients with Liver Scarring Due to Fatty Liver Disease
The FDA approved the first medication for the treatment of adults with noncirrhotic non-alcoholic steatohepatitis (NASH) with moderate to advanced liver scarring, to be used along with diet and exercise. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 14, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA Approves First-Ever Drug for Serious Liver Condition
(MedPage Today) -- The FDA granted accelerated approval to resmetirom (Rezdiffra) as the first treatment for adults with noncirrhotic non-alcoholic steatohepatitis (NASH), also now referred to as metabolic dysfunction-associated steatohepatitis... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 14, 2024 Category: American Health Source Type: news

Konica Minolta applauds winner, runners up of SPIE research award
Konica Minolta Healthcare Americas congratulates the winner and runners-up of the Best Student Paper Award given by the International Society for Optics and Photonics (SPIE) at its 2024 Medical Imaging Symposium in San Diego, CA. Konica Minolta sponsored the award as part of its continued commitment to the education and support of young scientists in medical imaging. The winner was Olivia F. Sandvold, a doctoral student in the Department of Bioengineering at the University of Pennsylvania for her paper, “Hybrid spectral CT system with clinical rapid kVp-switching x-ray tube and dual-layer detector for improved iodin...
Source: AuntMinnie.com Headlines - March 14, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news

Race, Ethnicity Plays Role in Liver Transplant Survival
THURSDAY, March 14, 2024 -- Researchers hope findings from a new study of liver transplant patients will lead to improved interventions for those from racial and ethnic minority groups. The study— led by researchers at UT Southwestern... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 14, 2024 Category: General Medicine Source Type: news

Researchers find promise in new potential treatment for liver failure
ROCHESTER, Minn. — A new drug has been shown to increase healing and regeneration of the liver after major surgery, according to a study published in the scientific journal Cell. Researchers hope that this could lead to more surgical options for patients diagnosed with advanced liver tumors and liver failure. "Thi s research is significant because this is the first drug of its kind to show an increase in healing and regeneration of the liver after… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 14, 2024 Category: Databases & Libraries Source Type: news

US FDA Approves Expanded Use Of Mirum's Liver Disease Drug US FDA Approves Expanded Use Of Mirum's Liver Disease Drug
The U.S Food and Drug Administration has approved the expanded use of Mirum Pharmaceuticals ' oral drug to treat itching caused by a liver disorder in patients aged five...Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - March 13, 2024 Category: Gastroenterology Tags: Gastroenterology Source Type: news

My son's bizarre symptom turned out to be liver cancer which doctors said would kill him but now he's beat ultra-rare diagnosis
Scans found a 'mass' on Jaxon Barnes' liver and he was diagnosed with hepatoblastoma, a form of liver cancer affecting around two million children globally. (Source: the Mail online | Health)
Source: the Mail online | Health - March 13, 2024 Category: Consumer Health News Source Type: news

Ionis Pharma's Fatty Liver Disease Drug Succeeds in Mid-stage Trial Ionis Pharma's Fatty Liver Disease Drug Succeeds in Mid-stage Trial
Ionis Pharmaceuticals said on Wednesday its experimental drug to treat a type of fatty liver disease met the main goal of reducing inflammation of the critical organ in a...Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - March 13, 2024 Category: Gastroenterology Tags: Gastroenterology Source Type: news

Millions of dementia patients may actually have 'very treatable' liver disease that has been misdiagnosed, according to 'unexpected' study
A new study of US veterans diagnosed with dementia found that many of them had liver disease, suggesting millions of people diagnosed with dementia could actually have a treatable condition. (Source: the Mail online | Health)
Source: the Mail online | Health - March 12, 2024 Category: Consumer Health News Source Type: news

Alcohol-Associated Liver Disease On the Rise: What to Know Alcohol-Associated Liver Disease On the Rise: What to Know
Dr Nancy Reau speaks with hepatologist Dr Ashwani Singal about how to identify alcohol-associated liver disease, the most common cause of advanced hepatic disease worldwide.Medscape Gastroenterology (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - March 11, 2024 Category: Gastroenterology Tags: Gastroenterology Expert Interview Source Type: news

Mayo Clinic Minute: What is hepatitis C?
It's estimated that 2 to 3 million people in the U.S. are living with the hepatitis C virus, and hundreds of thousands of them are undiagnosed. That's primarily because it tends to be asymptomatic in the initial stages until liver damage sets in decades later. A recent study coauthored by Dr. Karthik Gnanapandithan, a hospitalist at Mayo Clinic, found that nearly 40% of people with hepatitis C living in the U.S. are not even aware… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 11, 2024 Category: Databases & Libraries Source Type: news

Scientists Discover Toxic Microplastics In Every Human Placenta Tested In Study
Authored by Naveen Athrappully via The Epoch Times (emphasis ours), Harmful microplastics have been found in human placenta, with some of them known to trigger asthma, damage the liver, cause cancer, and impair…#naveenathrappully #epochtimes #richardthompson #universityofplymouth #ben #matthewcampen #microplastic #placentas #microplastics (Source: Reuters: Health)
Source: Reuters: Health - March 9, 2024 Category: Consumer Health News Source Type: news

Millions of dementia patients my actually have 'very treatable' liver disease that has been misdiagnosed, according to 'unexpected' study
A new study of US veterans diagnosed with dementia found that many of them had liver disease, suggesting millions of people diagnosed with dementia could actually have a treatable condition. (Source: the Mail online | Health)
Source: the Mail online | Health - March 9, 2024 Category: Consumer Health News Source Type: news

Semaglutide Cuts Liver Disease Severity in People With HIV
(MedPage Today) -- DENVER -- Semaglutide (Ozempic) reduced the amount of liver fat by nearly a third in people with HIV and metabolic dysfunction-associated steatotic liver disease (MASLD), the open-label phase IIb SLIM LIVER study showed. In... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - March 9, 2024 Category: Gastroenterology Source Type: news